Global Blue Light Treatment 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04255897

Publication Date:

April 24, 2025

Pages:

113

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Blue Light Treatment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Blue light treatment, also called PDT, uses light to treat certain conditions on or just under the skin. It鈥檚 considered a pain-free procedure. Blue light treatment becomes photodynamic therapy when it uses a combination of photosynthesizing (or light-sensitive) drugs and a high-intensity light source to activate them. The light used is a natural violet or blue light, and it鈥檚 considered to be an alternative treatment. Blue light therapy can only treat areas that the light can reach. So it鈥檚 typically used to treat conditions present on, or just underneath, the surface of the skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淏lue Light Treatment Industry Forecast鈥� looks at past sales and reviews total world Blue Light Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Blue Light Treatment sales for 2025 through 2031. With Blue Light Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blue Light Treatment industry.
This Insight Report provides a comprehensive analysis of the global Blue Light Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Blue Light Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Blue Light Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blue Light Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blue Light Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Blue Light Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Pure Blue Light Therapy
Blue and Red Light Dual Therapy
Others
Segmentation by Application:
Hospitals
Clinics
麻豆原创care
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mayo Clinic
Retina Group
Bausch Health
PhotoMedex
University of Iowa Hospitals & Clinics
Forefront
Arsenault Dermatology
Dermatology Associates of Virginia
Philps Koninklijke NV
Upper Hutt
LUSTRE庐 ClearSkin

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Blue Light Treatment 麻豆原创 Size (2020-2031)
2.1.2 Blue Light Treatment 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Blue Light Treatment by Country/Region (2020, 2024 & 2031)
2.2 Blue Light Treatment Segment by Type
2.2.1 Pure Blue Light Therapy
2.2.2 Blue and Red Light Dual Therapy
2.2.3 Others
2.3 Blue Light Treatment 麻豆原创 Size by Type
2.3.1 Blue Light Treatment 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Blue Light Treatment 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Blue Light Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 麻豆原创care
2.4.4 Others
2.5 Blue Light Treatment 麻豆原创 Size by Application
2.5.1 Blue Light Treatment 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Blue Light Treatment 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Blue Light Treatment 麻豆原创 Size by Player
3.1 Blue Light Treatment 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Blue Light Treatment Revenue by Player (2020-2025)
3.1.2 Global Blue Light Treatment Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Blue Light Treatment Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Blue Light Treatment by Region
4.1 Blue Light Treatment 麻豆原创 Size by Region (2020-2025)
4.2 Global Blue Light Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Blue Light Treatment 麻豆原创 Size Growth (2020-2025)
4.4 APAC Blue Light Treatment 麻豆原创 Size Growth (2020-2025)
4.5 Europe Blue Light Treatment 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Blue Light Treatment 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Blue Light Treatment 麻豆原创 Size by Country (2020-2025)
5.2 Americas Blue Light Treatment 麻豆原创 Size by Type (2020-2025)
5.3 Americas Blue Light Treatment 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blue Light Treatment 麻豆原创 Size by Region (2020-2025)
6.2 APAC Blue Light Treatment 麻豆原创 Size by Type (2020-2025)
6.3 APAC Blue Light Treatment 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Blue Light Treatment 麻豆原创 Size by Country (2020-2025)
7.2 Europe Blue Light Treatment 麻豆原创 Size by Type (2020-2025)
7.3 Europe Blue Light Treatment 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Blue Light Treatment by Region (2020-2025)
8.2 Middle East & Africa Blue Light Treatment 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Blue Light Treatment 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Blue Light Treatment 麻豆原创 Forecast
10.1 Global Blue Light Treatment Forecast by Region (2026-2031)
10.1.1 Global Blue Light Treatment Forecast by Region (2026-2031)
10.1.2 Americas Blue Light Treatment Forecast
10.1.3 APAC Blue Light Treatment Forecast
10.1.4 Europe Blue Light Treatment Forecast
10.1.5 Middle East & Africa Blue Light Treatment Forecast
10.2 Americas Blue Light Treatment Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Blue Light Treatment Forecast
10.2.2 Canada 麻豆原创 Blue Light Treatment Forecast
10.2.3 Mexico 麻豆原创 Blue Light Treatment Forecast
10.2.4 Brazil 麻豆原创 Blue Light Treatment Forecast
10.3 APAC Blue Light Treatment Forecast by Region (2026-2031)
10.3.1 China Blue Light Treatment 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Blue Light Treatment Forecast
10.3.3 Korea 麻豆原创 Blue Light Treatment Forecast
10.3.4 Southeast Asia 麻豆原创 Blue Light Treatment Forecast
10.3.5 India 麻豆原创 Blue Light Treatment Forecast
10.3.6 Australia 麻豆原创 Blue Light Treatment Forecast
10.4 Europe Blue Light Treatment Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Blue Light Treatment Forecast
10.4.2 France 麻豆原创 Blue Light Treatment Forecast
10.4.3 UK 麻豆原创 Blue Light Treatment Forecast
10.4.4 Italy 麻豆原创 Blue Light Treatment Forecast
10.4.5 Russia 麻豆原创 Blue Light Treatment Forecast
10.5 Middle East & Africa Blue Light Treatment Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Blue Light Treatment Forecast
10.5.2 South Africa 麻豆原创 Blue Light Treatment Forecast
10.5.3 Israel 麻豆原创 Blue Light Treatment Forecast
10.5.4 Turkey 麻豆原创 Blue Light Treatment Forecast
10.6 Global Blue Light Treatment Forecast by Type (2026-2031)
10.7 Global Blue Light Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Blue Light Treatment Forecast
11 Key Players Analysis
11.1 Mayo Clinic
11.1.1 Mayo Clinic Company Information
11.1.2 Mayo Clinic Blue Light Treatment Product Offered
11.1.3 Mayo Clinic Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Mayo Clinic Main Business Overview
11.1.5 Mayo Clinic Latest Developments
11.2 Retina Group
11.2.1 Retina Group Company Information
11.2.2 Retina Group Blue Light Treatment Product Offered
11.2.3 Retina Group Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Retina Group Main Business Overview
11.2.5 Retina Group Latest Developments
11.3 Bausch Health
11.3.1 Bausch Health Company Information
11.3.2 Bausch Health Blue Light Treatment Product Offered
11.3.3 Bausch Health Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Bausch Health Main Business Overview
11.3.5 Bausch Health Latest Developments
11.4 PhotoMedex
11.4.1 PhotoMedex Company Information
11.4.2 PhotoMedex Blue Light Treatment Product Offered
11.4.3 PhotoMedex Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 PhotoMedex Main Business Overview
11.4.5 PhotoMedex Latest Developments
11.5 University of Iowa Hospitals & Clinics
11.5.1 University of Iowa Hospitals & Clinics Company Information
11.5.2 University of Iowa Hospitals & Clinics Blue Light Treatment Product Offered
11.5.3 University of Iowa Hospitals & Clinics Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 University of Iowa Hospitals & Clinics Main Business Overview
11.5.5 University of Iowa Hospitals & Clinics Latest Developments
11.6 Forefront
11.6.1 Forefront Company Information
11.6.2 Forefront Blue Light Treatment Product Offered
11.6.3 Forefront Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Forefront Main Business Overview
11.6.5 Forefront Latest Developments
11.7 Arsenault Dermatology
11.7.1 Arsenault Dermatology Company Information
11.7.2 Arsenault Dermatology Blue Light Treatment Product Offered
11.7.3 Arsenault Dermatology Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Arsenault Dermatology Main Business Overview
11.7.5 Arsenault Dermatology Latest Developments
11.8 Dermatology Associates of Virginia
11.8.1 Dermatology Associates of Virginia Company Information
11.8.2 Dermatology Associates of Virginia Blue Light Treatment Product Offered
11.8.3 Dermatology Associates of Virginia Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Dermatology Associates of Virginia Main Business Overview
11.8.5 Dermatology Associates of Virginia Latest Developments
11.9 Philps Koninklijke NV
11.9.1 Philps Koninklijke NV Company Information
11.9.2 Philps Koninklijke NV Blue Light Treatment Product Offered
11.9.3 Philps Koninklijke NV Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Philps Koninklijke NV Main Business Overview
11.9.5 Philps Koninklijke NV Latest Developments
11.10 Upper Hutt
11.10.1 Upper Hutt Company Information
11.10.2 Upper Hutt Blue Light Treatment Product Offered
11.10.3 Upper Hutt Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Upper Hutt Main Business Overview
11.10.5 Upper Hutt Latest Developments
11.11 LUSTRE庐 ClearSkin
11.11.1 LUSTRE庐 ClearSkin Company Information
11.11.2 LUSTRE庐 ClearSkin Blue Light Treatment Product Offered
11.11.3 LUSTRE庐 ClearSkin Blue Light Treatment Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 LUSTRE庐 ClearSkin Main Business Overview
11.11.5 LUSTRE庐 ClearSkin Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.